Jazz Pharmaceuticals plc (JAZZ) has a market capitalization of $12.38B and trades at $201.06. The 52-week range is 95.49-198.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -34.4, Earnings Per Share (EPS) of $-5.84, annual revenue of $4.27B.
The stock has a beta of 0.23, operates in the Healthcare sector.
